A global gathering for thought leaders in longevity science and technology heads to Singapore in 2025 for its next edition.
The Founders Longevity Forum, a pivotal event in the global longevity sector, is set to return in 2025, with Singapore as its host. Known for convening influential voices from science, technology, investment and healthcare, the forum provides an unparalleled platform for discussing innovations and advancements aimed at extending healthspan and tackling the challenges of aging. As the longevity field continues to grow, the Singapore edition promises to bring together diverse perspectives from around the world, fostering collaboration across disciplines and industries.
Organized and hosted by Founders Forum, the National University of Singapore and Longevity.Technology, the 2025 event will feature a dynamic roster of speakers, including leaders from epigenetics, AI, cryomedicine and preventative healthcare. While the agenda is yet to be released, the Forum has revealed the event will be structured to allow attendees to engage with content relevant to their specific interests through two distinct tracks: Precision Geromedicine and Longevity Investment. The organizers have now announced the first wave of confirmed participants, each bringing a unique expertise to the table.
Speaker highlights
Elvin Siew – Co-Founder & CEO at Emagene Life and Avio Health
Siew drives advancements in healthcare using artificial intelligence and machine learning to revolutionize diagnostics and treatment options.
Hannah Went – Director of Operations at TruDiagnostic
Went oversees operations at TruDiagnostic, a leading provider of epigenetic testing that offers personalized health insights based on DNA methylation analysis.
Dr Jan Gruber – Associate Professor at National University of Singapore and Yale-NUS College
Gruber’s research spans aging, mitochondria, pharmacological interventions and biological aging clocks.
Tina Woods – Founder & CEO at Collider Health
Woods unites stakeholders from science, technology and policy to drive initiatives aimed at improving public health and fostering innovation in the longevity space.
Max Van Zanten – Investment & Business Development at Wellness Holding
Van Zanten specializes in wellness technologies, driving global marketing strategies for TechnoGym and fostering innovation in fitness.
Dr David Luu – CEO at Hearty
Luu combines his medical expertise with a passion for humanitarianism, democratizing cardiac care in underserved regions through mobile clinics and surgical interventions.
Professor Luigi Fontana – Professor at the University of Sydney
Fontana advocates for preventative healthcare approaches to promote long and healthy lives while addressing environmental sustainability.
Bhuvan Srinivasan – Chief Business Officer at Ultrahuman
With a background in private equity and research in continuous glucose monitoring, Srinivasan contributes to Ultrahuman’s mission of optimizing metabolic health while supporting startups as an angel investor.
Dr Emil Kendziorra – CEO at Tomorrow Bio
Kendziorra focuses on advancing biostasis and cryomedicine, leveraging his experience as a serial entrepreneur in technology and healthcare.
Petr Sramek – Managing Partner at Longevity.tech Fund
Sramek supports the growth of AI and longevity startups, providing mentorship and strategic guidance to emerging companies in the field.
Dr Anna Erat – Medical Director at Longevity Center Zurich
Erat blends clinical practice with research, advising on health strategies for a wide range of clients, from multi-morbid patients to elite athletes.
Greg MacPherson – Founder at SRW Laboratories
MacPherson is an experienced Chief Executive Officer with a demonstrated history of working in the health and wellness industry.
Yuta Lee – Founder & CEO at Accelerated Biosciences
Lee brings decades of expertise in commercializing human trophoblast stem cells, advancing ethical stem cell research.
Dr Siobhan Mitchell – Chief Science and Technology Officer at MitoQ
Mitchell’s work centers on clinical trial management, focusing on studies that address behavior change, mental health, cognition and metabolism.
Dr Cuilin Zhang – Professor at the NUS Yong Loo Lin School of Medicine
Zhang is a professor at the NUS Yong Loo Lin School of Medicine, and the founding Director of the Global Centre for Asian Women’s Health and the Lead for Population Health Study program of Asian Centre for Reproductive Longevity and Equity.
Luc Aguilar – International R&D Director at L’Oréal
Aguilar leads research in skin and hair microbiome science, translating findings into products addressing pollution, sun damage and skin disorders.
Dr David Dodick – Chief Science Officer and Co-Chair at Atria
Dodick brings his extensive experience in neurology, having founded multiple programs and held academic positions across prestigious institutions.
Dr Mattias Bernow – CEO at Cellcolabs
Bernow is the CEO of Cellcolabs, a Swedish biotech startup specializing in the industrial production of high-quality stem cells, making them widely available at scale.
Dr Frank Pun – Head at Insilico Medicine Hong Kong
Pun leads a team using AI-driven platforms for biological target discovery, advancing drug development through innovative approaches.
Dr Kevin Slawin – Founder and CEO of Eos SENOLYTIX
Slawin is the Founder and CEO of Eos SENOLYTIX, Inc, a gerotherapeutics company whose lead programs are focused on proprietary senolytic peptides, that may restore the youthful balance of aged or “senescent” and young cells throughout the organs of the body.
Professor Andrea Maier – NUS Oon Chiew Seng Professor in Medicine and Founder at Chi Longevity
Maier’s expertise in gerontology and geriatrics focuses on preventing age-related diseases and extending healthspan.
Phil Newman – CEO and Founder at Longevity.Technology
Newman, a driving force in longevity innovation, connects investors and startups through his work with Longevity.Technology and First Longevity.
The Founders Longevity Forum promises to be a vital event for fostering meaningful dialogue and collaboration across the longevity ecosystem. Further updates, including the agenda and additional speakers, are expected soon.
